(University of California - Riverside) A stroke treatment developed by a researcher at the University of California, Riverside, has moved toward clinical trials. The treatment focuses on neuregulins, a family of naturally occurring proteins that has shown promise for treating stroke, a leading cause of death in the United States and the major cause of long-term disability.
Original Article: Hope on the horizon for treating stroke